论文信息 - RP-3500: A Novel, Potent, and Selective ATR Inhibitor that is Effective in Preclinical Models as a Monotherapy and in Combination with PARP Inhibitors - 字舞流文

RP-3500: A Novel, Potent, and Selective ATR Inhibitor that is Effective in Preclinical Models as a Monotherapy and in Combination with PARP Inhibitors

R. Stocco | A. Roulston | Jordan T. F. Young | Y. Mamane | K. Skorey | M. Hamel | Charles Pellerin | Michal Zimmermann | Zuomei Li | H. Alam | Amandine Chefson | R. Papp | V. Rimkunas | M. Zinda | William W. Yang | L. Fader | W. Black | A. Veloso | Chloe Fugère-Desjardins | Marie-Eve Leclaire | Shou Yun Yin | V. Dumais | A. Skeldon | Amina Mulani | Stéphane Dorich | S. Fournier | Émilie Dumas-Bérube | Valerie Dumais | Li Li | Sabrina Vignini-Hammond | Hunain Alam | S. Yin